Emerging Longevity Ventures

Emerging Longevity Ventures

Emerging Longevity Ventures is a venture capital firm founded in Mountain View, California, with an additional office in San Diego. The firm focuses on investments that aim to extend human healthspan, a departure from traditional healthcare IT or biotech strategies. Public records indicate the firm targets early-stage companies across AI/ML, digital health, and agritech/foodtech sectors, though specific founding details and principal names remain undisclosed. The firm's investment strategy spans multiple asset classes, including early-stage venture capital, with a focus on AI-driven diagnostics, digital health platforms, and agritech for nutraceutical supply chains. Geographic reach appears concentrated in North America, leveraging the technology ecosystem of Silicon Valley and the life science infrastructure of San Diego. No confirmed portfolio companies, co-investors, or deal sizes are publicly available, suggesting the firm may operate with a low public profile. Team size and total deployment are not publicly disclosed. The firm maintains offices in two California hubs, which may facilitate separate sourcing channels: one for AI and software-based longevity plays, and one for biotech and clinical trials. No adjacent vehicles, such as philanthropic foundations or co-investment clubs, have been identified in public records. Emerging Longevity Ventures' structural differentiator lies in its explicit focus on healthspan extension — a niche that sits at the intersection of venture capital and impact investing. The firm may employ a thesis-driven approach that targets both technology and biology, differentiating it from generalist healthcare VCs. Governance and succession structures are not publicly documented, and no recent operational events have been reported.